Dr. Carly Rose explains how adopting more advanced DED tools like OptiLIGHT in her practice helps her achieve more for her patients, even with less time.
After OptiLIGHT, Patients Shoulder Smaller Burden of Traditional Home Care
In our referral practice, where it’s common to see 10 new referrals a week for dry eye disease (DED), patients’ top priority is to lighten the burden of DED. This chronic, progressive condition affects their quality of life and forces them to think about their eyes all the time. Many of them have seen multiple doctors and tried medications, artificial tears, warm compresses, punctal plugs and other therapies.
The Unequivocal Benefits of Incorporating OptiLIGHT Into Your Dry Eye Practice
Incorporating OptiLIGHT into my practice has made a real difference in patients with meibomian gland dysfunction (MGD) and evaporative dry eye. Lumenis light therapy is the first and only that is FDA-approved for DED, and that is a strong affirmation of safety and efficacy for doctors who are considering implementing OptiLIGHT in their practice as well.
Digital Duet in Togo: Insights from an Unforgettable Clinical and Professional Journey
In Africa, glaucoma presents a uniquely difficult problem, as its high prevalence is compounded by economic barriers to essential medical care.
Selective laser trabeculoplasty (SLT) is a potentially transformative modality in this setting, presenting an opportunity for quick, safe, and effective long-term treatment.
During a trip to Togo, West Africa, Dr.Shlomo Melamed, MD and his colleagues taught local ophthalmologists to perform SLT using Digital Duet.
The Ultimate Guide to OptiLight for Dry Eye
Hear from two prominent dry eye specialists in the Ultimate Guide to OptiLight for Dry Eye and learn about how they incorporated OptiLight into the practice, access comprehensive information on the history of IPL technology, and gain clear understanding on the unique benefits of OptiLight. The guide includes clinical data on how OptiLight can improve meibomian gland dysfunction through several mechanisms of action, along with pre and post treatment care and quick tips for performing the procedure. This ultimate guide provides scripts for easy ways to talk to patients about OptiLight and valuable recommendations from experts who have leveraged OptiLight to provide a real solution to their patients and elevate their practice success.
Lumenis Vision Is Ready to Partner with Doctors Across the U.S. at 2023 Eyecare Meetings and Brilliance Vision Mastery Events
Eager for hands-on learning with Lumenis’ award-winning, innovative technology? Join us at Brilliance and industry meetings to be part of the conversation.
Itay Mayer, VP and Managing Director of Lumenis Vision, shares exciting product updates about OptiLight 2.0 and insights into Lumenis’ consumer campaign at VEE 2023
Itay Mayer, Vice President and Managing Director of Lumenis Vision, caught up with Optometry Times® to share an update on the company and its products, which was showcased during the 2023 Vision Expo East meeting in New York, New York.
The Business of Dry Eye: 4 Steps to Boosting Practice Profitability with In-Office Treatments
Researchers found that 20 tear cytokines decreased significantly after IPL treatment, illustrating how IPL suppresses DED’s vicious cycle of inflammation.
Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye
Researchers found that 20 tear cytokines decreased significantly after IPL treatment, illustrating how IPL suppresses DED’s vicious cycle of inflammation.
Three Ways OptiLight Is Changing Dry Eye Management in Our Practice
Drs. Rachna Murthy and Jonathan Roos tapped into OptiLight to revolutionize their dry eye management services, addressing patient pathology and rejuvenating their appearance